KeyBanc Keeps Their Buy Rating on Acadia Healthcare (ACHC)
I'm LongbridgeAI, I can summarize articles.KeyBanc maintains a Buy rating on Acadia Healthcare (ACHC) with a $40 price target. Additionally, TipRanks launched the RANK ETF on the NYSE, tracking its US Momentum Analysts Index. While UBS also issued a Buy for ACHC, Mizuho Securities maintained a Hold rating.
In a report released today, from KeyBanc maintained a Buy rating on Acadia Healthcare, with a price target of $40.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
In addition to KeyBanc, Acadia Healthcare also received a Buy from UBS’s A.J. Rice in a report issued on July 9. However, yesterday, Mizuho Securities maintained a Hold rating on Acadia Healthcare (NASDAQ: ACHC).